Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0140-6736(97)26041-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Hydrogel coils in intracranial aneurysm treatment: a multicenter, prospective, randomized open-label trial.
J Neurosurg
January 2025
19Division of Medical Statistics, Division of Data Science, Foundation for Biomedical Research and Innovation at Kobe; and.
Objective: Studies have demonstrated the effectiveness of hydrogel-coated coils (HGCs) to achieve the composite endpoint of decreased recanalization rates and greater safety. Herein, the authors aimed to assess the true ability of second-generation HGCs to prevent recanalization.
Methods: This randomized controlled study, the HYBRID (Hydrocoil Versus Bare Platinum Coil in Recanalization Imaging Data) trial, comparing HGCs with bare platinum coils (BPCs), was conducted in 43 Japanese institutions.
Effects of Atmospheric Pollutants on Volatile-Mediated Insect Ecosystem Services.
Glob Chang Biol
January 2025
Department of Environmental and Biological Sciences, Faculty of Science, Forestry and Technology, University of Eastern Finland, Kuopio, Finland.
Primary and secondary atmospheric pollutants, including carbon monoxide (CO), carbon dioxide (CO), nitrogen oxides (NO), ozone (O), sulphur dioxide (SO) and particulate matter (PM/PM) with associated heavy metals (HMs) and micro- and nanoplastics (MPs/NPs), have the potential to influence and alter interspecific interactions involving insects that are responsible for providing essential ecosystem services (ESs). Given that insects rely on olfactory cues for vital processes such as locating mates, food sources and oviposition sites, volatile organic compounds (VOCs) are of paramount importance in interactions involving insects. While gaseous pollutants reduce the lifespan of individual compounds that act as olfactory cues, gaseous and particulate pollutants can alter their biosynthesis and emission and exert a direct effect on the olfactory system of insects.
View Article and Find Full Text PDFPharmacist-led antimicrobial stewardship at transitions of care from inpatient hospital to home: a scoping review.
Antimicrob Steward Healthc Epidemiol
August 2024
Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Objective: To summarize available literature and highlight research gaps pertaining to the role of a pharmacist in providing antimicrobial stewardship (AMS) interventions for antibiotics at transitions of care (TOC) from inpatient hospital settings to home.
Design: Scoping review.
Methods: This scoping review follows the Arksey and O'Malley methodological framework.
Matching Into Integrated Plastic Surgery: The Impact of USMLE Step 1 Transition to Pass/Fail: Did the 2019 Predictions Come True in 2024?
Plast Reconstr Surg Glob Open
January 2025
Department of Plastic and Reconstructive Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.
Background: The first class of integrated plastic surgery residency applicants with pass/fail (P/F) step 1 assessments occurred during the 2023-2024 Match cycle. This study analyzes the results of a 2024 postmatch survey to program directors (PDs) regarding the impact of the conversion to P/F step 1 scoring and compares the results to the 2019 survey that attempted to predict how this conversion would influence decision-making when it was initially announced.
Methods: A 26-item survey evaluating PDs' perspectives on applicant characteristics and the application process following P/F step 1 scoring was distributed March 2024.
SGLT2 Inhibitor Use in Chronic Kidney Disease: Supporting Cardiovascular, Kidney, and Metabolic Health.
Kidney Med
August 2024
School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
Originally developed for use in type 2 diabetes mellitus (T2DM), sodium-glucose co-transporter-2 (SGLT2) inhibitors demonstrated diverse cardiovascular- and kidney-protective effects in large outcome trials. Their subsequent approval as a treatment for chronic kidney disease (CKD) marked a pivotal shift in the landscape of CKD management. Further to this, the approval of dapagliflozin and empagliflozin for use in patients with CKD with and without T2DM afforded new treatment opportunities for this population.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!